Open AccessVenetoclax with high‐dose methotrexate and rituximab seem effective and well‐tolerated in the treatment of central nervous system involvement of chronic lymphocytic leukemia: A case report
Author(s) -
Beziat Guillaume,
Gauthier Martin,
Protin Caroline,
Oberic Lucie,
Lerebours Fleur,
Carlier Jasmine,
Ysebaert Loïc
Publication year - 2020
Publication title -
clinical case reports
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.21
H-Index - 9
ISSN - 2050-0904
DOI - 10.1002/ccr3.2580
Subject(s) - venetoclax , medicine , rituximab , methotrexate , chronic lymphocytic leukemia , central nervous system , leukemia , oncology , lymphoma
Venetoclax with high‐dose methotrexate and rituximab seem effective and safe to treat central nervous system involvement of chronic lymphocytic leukemia.